FI972542A7 - Transdermaalijärjestelmä useamman aktiivisen aineen samanaikaista anta mista varten - Google Patents

Transdermaalijärjestelmä useamman aktiivisen aineen samanaikaista anta mista varten Download PDF

Info

Publication number
FI972542A7
FI972542A7 FI972542A FI972542A FI972542A7 FI 972542 A7 FI972542 A7 FI 972542A7 FI 972542 A FI972542 A FI 972542A FI 972542 A FI972542 A FI 972542A FI 972542 A7 FI972542 A7 FI 972542A7
Authority
FI
Finland
Prior art keywords
active substances
simultaneous administration
multiple active
transdermal system
transdermal
Prior art date
Application number
FI972542A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI972542L (fi
FI972542A0 (fi
Inventor
Bruno Bevan
Cecile Aillaud
Original Assignee
Laboratoires Dhygiene Et De Dietetique
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Laboratoires Dhygiene Et De Dietetique filed Critical Laboratoires Dhygiene Et De Dietetique
Publication of FI972542L publication Critical patent/FI972542L/fi
Publication of FI972542A0 publication Critical patent/FI972542A0/fi
Publication of FI972542A7 publication Critical patent/FI972542A7/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30—Oestrogens

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Dermatology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Electrotherapy Devices (AREA)
  • Radiation-Therapy Devices (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
FI972542A 1994-12-21 1995-12-19 Transdermaalijärjestelmä useamman aktiivisen aineen samanaikaista anta mista varten FI972542A7 (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9415416A FR2728463A1 (fr) 1994-12-21 1994-12-21 Systeme transdermique d'administration simultanee de plusieurs principes actifs
PCT/FR1995/001696 WO1996019203A1 (fr) 1994-12-21 1995-12-19 Systeme transdermique d'administration simultanee de plusieurs principes actifs

Publications (3)

Publication Number Publication Date
FI972542L FI972542L (fi) 1997-06-16
FI972542A0 FI972542A0 (fi) 1997-06-16
FI972542A7 true FI972542A7 (fi) 1997-06-16

Family

ID=9470067

Family Applications (1)

Application Number Title Priority Date Filing Date
FI972542A FI972542A7 (fi) 1994-12-21 1995-12-19 Transdermaalijärjestelmä useamman aktiivisen aineen samanaikaista anta mista varten

Country Status (23)

Country Link
US (1) US5919477A (enExample)
EP (1) EP0800386B1 (enExample)
JP (1) JPH10510823A (enExample)
KR (1) KR980700071A (enExample)
CN (1) CN1072929C (enExample)
AT (1) ATE173164T1 (enExample)
AU (1) AU692042B2 (enExample)
CA (1) CA2208374A1 (enExample)
CZ (1) CZ183297A3 (enExample)
DE (1) DE69506007T2 (enExample)
DK (1) DK0800386T3 (enExample)
ES (1) ES2125679T3 (enExample)
FI (1) FI972542A7 (enExample)
FR (1) FR2728463A1 (enExample)
HU (1) HUT77384A (enExample)
NO (1) NO972467L (enExample)
NZ (1) NZ298826A (enExample)
PL (1) PL182452B1 (enExample)
RU (1) RU2157193C2 (enExample)
SI (1) SI0800386T1 (enExample)
SK (1) SK280631B6 (enExample)
UA (1) UA42806C2 (enExample)
WO (1) WO1996019203A1 (enExample)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020188037A1 (en) * 1999-04-15 2002-12-12 Chudzik Stephen J. Method and system for providing bioactive agent release coating
ATE219693T1 (de) 1998-04-27 2002-07-15 Surmodics Inc Bioaktive wirkstoffe freisetzende beschichtungen
DE10025970C2 (de) * 2000-05-25 2002-04-25 Lohmann Therapie Syst Lts Estrogenhaltiges Pflaster mit einem Wirkstoffreservoir auf der Basis von Ethylcellulose und einem Ethylen-Vinylacetat-Vinylpyrrolidon-Copolymer und seine Verwendung
US6682757B1 (en) 2000-11-16 2004-01-27 Euro-Celtique, S.A. Titratable dosage transdermal delivery system
DE10141651B4 (de) * 2001-08-24 2007-02-15 Lts Lohmann Therapie-Systeme Ag Transdermales Therapeutisches System (TTS) mit dem Wirkstoff Fentanyl und Verfahren zu seiner Herstellung
US7097850B2 (en) 2002-06-18 2006-08-29 Surmodics, Inc. Bioactive agent release coating and controlled humidity method
US7243788B2 (en) * 2003-10-22 2007-07-17 Kimberly-Clark Worldwide, Inc. Package for segregating and mixing substances
JP2007509951A (ja) * 2003-10-28 2007-04-19 ノーヴェン ファーマシューティカルズ インコーポレイテッド 経皮的なドラッグデリバリーシステムにおける医薬品の損失及び送達を制御するための組成物及び方法
JP2007532187A (ja) 2004-04-06 2007-11-15 サーモディクス，インコーポレイティド 生物活性物質のためのコーティング組成物
US8685421B2 (en) 2006-07-07 2014-04-01 Surmodics, Inc. Beaded wound spacer device
US20090202609A1 (en) * 2008-01-06 2009-08-13 Keough Steven J Medical device with coating composition
US9301920B2 (en) 2012-06-18 2016-04-05 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
CA2856520C (en) 2011-11-23 2021-04-06 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
US20130338122A1 (en) 2012-06-18 2013-12-19 Therapeuticsmd, Inc. Transdermal hormone replacement therapies
US20150196640A1 (en) 2012-06-18 2015-07-16 Therapeuticsmd, Inc. Progesterone formulations having a desirable pk profile
US10806740B2 (en) 2012-06-18 2020-10-20 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
US10806697B2 (en) 2012-12-21 2020-10-20 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
WO2014062839A1 (en) 2012-10-16 2014-04-24 Surmodics, Inc. Wound packing device and methods
US10471072B2 (en) 2012-12-21 2019-11-12 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US11266661B2 (en) 2012-12-21 2022-03-08 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US9180091B2 (en) 2012-12-21 2015-11-10 Therapeuticsmd, Inc. Soluble estradiol capsule for vaginal insertion
US10568891B2 (en) 2012-12-21 2020-02-25 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10537581B2 (en) 2012-12-21 2020-01-21 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US11246875B2 (en) 2012-12-21 2022-02-15 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
AR100562A1 (es) 2014-05-22 2016-10-12 Therapeuticsmd Inc Composición farmacéutica de estradiol y progesterona para terapia de reemplazo hormonal
US10201457B2 (en) 2014-08-01 2019-02-12 Surmodics, Inc. Wound packing device with nanotextured surface
US10328087B2 (en) 2015-07-23 2019-06-25 Therapeuticsmd, Inc. Formulations for solubilizing hormones
US10286077B2 (en) 2016-04-01 2019-05-14 Therapeuticsmd, Inc. Steroid hormone compositions in medium chain oils
AU2017239645A1 (en) 2016-04-01 2018-10-18 Therapeuticsmd, Inc. Steroid hormone pharmaceutical composition
US11633405B2 (en) 2020-02-07 2023-04-25 Therapeuticsmd, Inc. Steroid hormone pharmaceutical formulations

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4666441A (en) * 1985-12-17 1987-05-19 Ciba-Geigy Corporation Multicompartmentalized transdermal patches
US5023084A (en) * 1986-12-29 1991-06-11 Rutgers, The State University Of New Jersey Transdermal estrogen/progestin dosage unit, system and process
US4911707A (en) * 1987-02-13 1990-03-27 Ciba-Geigy Corporation Monolithic user-activated transdermal therapeutic system
US5071656A (en) * 1987-03-05 1991-12-10 Alza Corporation Delayed onset transdermal delivery device
DE3714140A1 (de) * 1987-04-28 1988-11-10 Lohmann Therapie Syst Lts Wirkstoffhaltiges pflaster zur kontrollierten verabreichung von wirkstoffen an die haut, seine verwendung sowie verfahren zur gesteuerten verabreichung von wirkstoffen an die haut
US5538736A (en) * 1987-04-28 1996-07-23 Lts Lohmann Therapie-Systeme Gmbh Active substance-containing plaster for the controlled administration of active substances to the skin
DE3903794A1 (de) * 1989-02-09 1990-08-16 Lohmann Therapie Syst Lts Therapeutisches system zur transdermalen oder transmucosalen verabreichung von wirkstoffen und seine verwendung
US5788983A (en) * 1989-04-03 1998-08-04 Rutgers, The State University Of New Jersey Transdermal controlled delivery of pharmaceuticals at variable dosage rates and processes
US5350581A (en) * 1989-12-14 1994-09-27 Pharmetrix Corporation Method for manufacturing transdermal devices
US5064422A (en) * 1990-10-18 1991-11-12 Bertek, Inc. Twin patch applicator
DE4336557C2 (de) * 1993-05-06 1997-07-17 Lohmann Therapie Syst Lts Estradiolhaltiges transdermales therapeutisches System, Verfahren zu seiner Herstellung und seine Verwendung

Also Published As

Publication number Publication date
NO972467L (no) 1997-06-17
PL182452B1 (pl) 2002-01-31
UA42806C2 (uk) 2001-11-15
DE69506007T2 (de) 1999-06-10
DE69506007D1 (de) 1998-12-17
NO972467D0 (no) 1997-05-30
ATE173164T1 (de) 1998-11-15
US5919477A (en) 1999-07-06
AU4450596A (en) 1996-07-10
FR2728463A1 (fr) 1996-06-28
EP0800386A1 (fr) 1997-10-15
HK1004375A1 (en) 1998-11-27
HUT77384A (hu) 1998-04-28
SK280631B6 (sk) 2000-05-16
JPH10510823A (ja) 1998-10-20
DK0800386T3 (da) 1999-07-26
CN1170359A (zh) 1998-01-14
FI972542L (fi) 1997-06-16
CN1072929C (zh) 2001-10-17
FI972542A0 (fi) 1997-06-16
KR980700071A (ko) 1998-03-30
CZ183297A3 (en) 1997-10-15
EP0800386B1 (fr) 1998-11-11
NZ298826A (en) 1998-10-28
ES2125679T3 (es) 1999-03-01
WO1996019203A1 (fr) 1996-06-27
CA2208374A1 (en) 1996-06-27
AU692042B2 (en) 1998-05-28
FR2728463B1 (enExample) 1997-02-21
SI0800386T1 (en) 1999-04-30
RU2157193C2 (ru) 2000-10-10
SK79197A3 (en) 1997-12-10
PL320883A1 (en) 1997-11-10
MX9704527A (es) 1997-10-31

Similar Documents

Publication Publication Date Title
FI972542A7 (fi) Transdermaalijärjestelmä useamman aktiivisen aineen samanaikaista anta mista varten
FI973320A7 (fi) Kiinteitä aktiiviainetta sisältäviä valmisteita
KR950703383A (ko) 초음파 경피약제전달 시스템(ultrasonic transdermal drug delivery system)
IT8847798A0 (it) Sistemi terapeutici transtermici per combinazioni di sostanze attive
EE9700241A (et) Farmatseutiline kompositsioon transdermaalseks manustamiseks
NO981638D0 (no) Legemiddel- avgivelsesanordning for to eller flere aktive forbindelser
FI960556A7 (fi) Transdermaalinen aktiivisten lääkeaineiden hitaan virtauksen antojärje stelmä
DK618186D0 (da) Konfektureindgiftssystem til aktive stoffer
KR970006279A (ko) 약제학적 활성 성분으로서의 6-디메틸아미노메틸-1-페닐-사이클로헥산 화합물
IS4102A (is) Kerfi til að skammta lyfjafræðilega virk efni
FI955259L (fi) Estradiolia sisältävä transdermaalinen terapeuttinen systeemi
IT1283102B1 (it) Composizione terapeutica per la somministrazione transdermica di un principio attivo estrogeno o progestinico o di loro miscele
FI945311A7 (fi) Oksibutyniinin transdermaalinen annostelu
FI963045L (fi) Farmaseuttisesti aktiiviset yhdisteet ja liposomit ja menetelmä niiden käyttämiseksi
ATE241350T1 (de) Transdermale verabreichungsform von flurbiprofen
FI953533L (fi) Transdermaalinen terapeuttinen järjestelmä, jossa on galantamiinia vaikuttavana aineena
DE69530004D1 (de) Transdermale verabreichung von apomorphin
FI954990L (fi) Aktiiviainetta sisältävä transdermaalinen valmiste
ITTV920120A0 (it) Struttura di dispositivo di frenata, particolarmente per pattini
FI961437A0 (fi) Vaikuttavan aineen luovuttava systeemi
FI961282L (fi) Transdermaalinen terapeuttinen systeemi, jossa on asetyylisalisyylihappo vaikuttavana aineena
FI925778A0 (fi) Farmaceutiskt aktiva bensokinazolinfoereningar
DE59500266D1 (de) Transdermales therapeutisches System zur Applikation von Naloxon
FI943201L (fi) Vaikuttavaa ainetta luovuttava laite
FI964619A0 (fi) Epilepsialääkkeiden iholle annostelu